ema.europe.eu was on that website. I am so sorry that I am unable to paste the info. It gave the contents of the capsule and description of capsule among other things.
Another Italian company, Angelina Pharma, wants to enter the United States pharmaceutical market. Today Angelina bought U.S. based CPRX for $ 4.1 Billion, or $31.5/share. We have 17K shares of CPRX, bought at $0.52/share. Catalyst has 2-3 FDA- approved products in rare disease market. Does Recordati have similar plans with Amarin current partnership?